CCL5 and myeloid sarcoma: CCL5 was included in the analysis as a previous study of human primary astrocytes pinpointed this chemokine as the most prominently expressed upon astrocyte activation (33) and CCL5 is elevated in the CSF of patients with MS (31, 34).